ClariVein^®, mechanochemical endovenous ablation: patient selection and perspective

Abstract

The American Venous Forum and the National Institute for Health and Care Excellence recommend endothermal ablation (ETA) techniques as the first line treatment for superficial venous incompetence. However, these techniques require the use of tumescent anaesthesia prior to energy delivery, which may be a source of discomfort for the patient and can prolong procedure time. Recently, nonthermal, nontumescent (NTNTs) techniques such as mechanochemical ablation (MOCA) have been developed to address some of the negative aspects associated with ETA. This article reviews this technique from a patient selection and perspective point view.

Keywords:

• endovenous ablation
• varicose veins
• venous disease
• mechanochemical ablation

Acknowledgements

The research was supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial College Healthcare NHS Trust and Imperial College London. The views expressed are those of the authors and not necessarily those of the NHS, NIHR or the Department of Health. SO is supported by an NIHR Clinical Lectureship and acknowledges support from the NIHR Imperial Biomedical Research Centre.

Disclosure

Mr Roshan Bootun reports grants from Graham-Dixon Charitable Trust and Kreussler, outside the submitted work. The authors report no other conflicts of interest in this work.